Multiple Manufacturers

IFEX

Manufacturer:

Multiple Manufacturers

Ifex HCPCS:

J9208

HCPCS Code Descriptor:

Injection, ifosfamide, 1 gram

Category:

J Code

Ifex NDCs:

10019-0926-02, 00143-9530-01, 00338-3993-01, 63323-0142-10, 10019-0925-01, 00338-3991-01, 00143-9531-01, 63323-0142-12

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

63323-0142-12

About Ifex:

IFEX is an Oncology drug manufactured by Baxter Healthcare and administered via the Intravenous route of administration. The J Code: J9208 is aligned to the drug IFEX.

IFEX is a cancer medication used to treat numerous types of cancer. This medication works by slowing down and stopping the growth of cancer cells. IFEX is a generic medication that is produced by the companies Hikma pharmaceuticals, Sicor, Baxter, and Fresenius Kabi. This medication was aligned to the HCPCS code J9208 January 1st of 2018 and is still currently aligned to this HCPCS code.

ACCESS PRICING AND MORE BY REGISTERING

J9208 Added Date:

January 1, 1990

J9208 Effective Date:

January 1, 2018

J9208 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ifex billing and coding information.
Our team did not identify a source for Ifex patient assistance information. Please reach out to our team if you feel that this is a mistake.
IFEX prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for IFEX. Please check back in a few weeks.